Dismal commercial sales because NO public reimbursement. Why? No FDA approval for any indication. No USA Medicare. No UK sales. No UK PBS. No TGA approval. No Aussie PBS. No Nice EU.
GBA Germany approval for Trial. Still a long way off in my opinion. Could be surprised but won’t hold my breath.
EU MDR approval maybe used as a basis for TGA. Still will take time. Delays. Etc etc etc.
Meanwhile, $3 million cash burn per quarter. Every quarter. And NO Deal? Where is a DEAL? Any? Partnership, JV, Takeover? Anything? Where is it?
Back to sleep now.
OSL Price at posting:
0.7¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)